Effect of a sustained reduction in plasma free fatty acid concentration on intramuscular long-chain fatty Acyl-CoAs and insulin action in type 2 diabetic patients.
about
Influence of amino acids, dietary protein, and physical activity on muscle mass development in humansObesity and its metabolic complications: the role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease.Viewpoints on the way to the consensus session: where does insulin resistance start? The adipose tissue.The T-allele of TCF7L2 rs7903146 associates with a reduced compensation of insulin secretion for insulin resistance induced by 9 days of bed rest.Effects of growth hormone and free fatty acids on insulin sensitivity in patients with type 1 diabetes.Knockdown of the gene encoding Drosophila tribbles homologue 3 (Trib3) improves insulin sensitivity through peroxisome proliferator-activated receptor-γ (PPAR-γ) activation in a rat model of insulin resistanceEffects of pioglitazone on intramyocellular fat metabolism in patients with type 2 diabetes mellitus.Effects of exenatide plus rosiglitazone on beta-cell function and insulin sensitivity in subjects with type 2 diabetes on metformin.Pathogenesis of insulin resistance in skeletal muscle.Insulin resistance, lipotoxicity, type 2 diabetes and atherosclerosis: the missing links. The Claude Bernard Lecture 2009Chronic reduction of plasma free fatty acid improves mitochondrial function and whole-body insulin sensitivity in obese and type 2 diabetic individualsReduction in inflammatory gene expression in skeletal muscle from Roux-en-Y gastric bypass patients randomized to omentectomyRelatively low endogenous fatty acid mobilization and uptake helps preserve insulin sensitivity in obese women.Apelin decreases lipolysis via G(q), G(i), and AMPK-Dependent Mechanisms.Treatment with CNX-011-67, a novel GPR40 agonist, delays onset and progression of diabetes and improves beta cell preservation and function in male ZDF ratsReversible high affinity inhibition of phosphofructokinase-1 by acyl-CoA: a mechanism integrating glycolytic flux with lipid metabolism.Apelin and insulin resistance: another arrow for the quiver?Inhibition of lipolysis in Type 2 diabetes normalizes glucose disposal without change in muscle glycogen synthesis rates.Evidence for a direct effect of the NAD+ precursor acipimox on muscle mitochondrial function in humans.Skeletal muscle triglycerides, diacylglycerols, and ceramides in insulin resistance: another paradox in endurance-trained athletes?Mammalian triacylglycerol metabolism: synthesis, lipolysis, and signalingCellular mechanism of insulin resistance in nonalcoholic fatty liver diseaseEffects of nicotinic acid on gene expression: potential mechanisms and implications for wanted and unwanted effects of the lipid-lowering drug.Adipose triglyceride lipase deletion from adipocytes, but not skeletal myocytes, impairs acute exercise performance in miceElevated nocturnal NEFA are an early signal for hyperinsulinaemic compensation during diet-induced insulin resistance in dogs.Nicotine and insulin resistance: when the smoke clears.Optimized mixture of hops rho iso-alpha acids-rich extract and acacia proanthocyanidins-rich extract reduces insulin resistance in 3T3-L1 adipocytes and improves glucose and insulin control in db/db miceBiomarkers of Ectopic Fat Deposition: The Next Frontier in Serum Lipidomics.Thematic review series: patient-oriented research. Free fatty acid metabolism in human obesity.Effect of acute physiological hyperinsulinemia on gene expression in human skeletal muscle in vivo.Effect of Dapagliflozin With and Without Acipimox on Insulin Sensitivity and Insulin Secretion in T2DM Males.Metabolic Effects of Long-Term Reduction in Free Fatty Acids With Acipimox in Obesity: A Randomized TrialInsulin sensitivity: modulation by nutrients and inflammation.Eicosanoids in metabolic syndrome.Skeletal muscle insulin resistance: roles of fatty acid metabolism and exerciseIntramuscular lipid metabolism, insulin action, and obesity.Reducing dietary fat from a meal increases the bioavailability of exogenous carbohydrate without altering plasma glucose concentration.Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitusGlucagon-mediated impairments in hepatic and peripheral tissue nutrient disposal are not aggravated by increased lipid availability.Relation of adipose tissue to metabolic flexibility
P2860
Q27003307-DA4C9480-E5EA-4D57-845F-50113B6AA1F6Q33580624-F6C5BE45-8953-4F0B-8DA4-19B705D2D9AEQ33610688-6F1C87B7-0CD7-4762-84AA-CAC225888FE4Q33750703-1141DD3D-E377-4C98-A3C8-F6B9E312187DQ33759055-5A8DBA12-0C4D-4969-8461-D4C0E1067160Q33772290-A51D610A-A005-4741-95D8-7C870CFC35B9Q33786881-CF52390D-21FD-450B-A5FA-6DE9A2EFAF86Q33804747-869910B5-D8CD-4291-AD8F-67C081BCC045Q33812448-487E91DB-EFA7-4083-B036-EAC4EB182060Q33880303-4828FEAD-386E-4EFA-8154-53943B8363EDQ33959764-DB39DE7E-6CFB-43BA-9922-EBB77F0EB9EDQ34110159-D58B5144-452A-4939-8ECF-23CD340D3EADQ34438633-5FD35716-08C5-4F3B-A7EF-89BD68A12E46Q34548928-CF0307F4-5CB5-4692-B75A-03C0910293FDQ34732874-0848E841-742D-41FD-95AF-B29410B57F47Q34752001-66025273-D5A7-4749-8B5D-DA490C78AA4FQ35166911-A50B381B-9FF4-433D-8887-CB301650DF02Q35215573-A8DD52C5-D99C-4932-BCA9-A12D1ECED741Q35220552-73B447C7-308A-4374-A0D1-5FDBF0907ED7Q35227175-91F54EEA-82C0-4FE7-AB73-E7E6D6BB5F80Q35235426-A1F81FEA-B3EA-44C9-8684-6CE686AC2CAFQ35239565-1E229EB5-460C-4C24-ACF6-8388EDD11333Q35432791-682F50E9-2BA3-4068-827F-A022498C131BQ35622450-C9A5C4D4-D5EF-41E4-8DD4-C4A695A171F1Q36113667-2F87C57F-1C99-49C9-8B05-2E780AA5F554Q36410690-24DD29AB-A91B-4DD5-BEDA-679838FA5764Q36424615-F876D9C2-0ECA-4707-80F5-66A1C24B9DDDQ36431633-4230612D-082F-4132-99E3-9B7FC62EB95EQ36473651-FED0A6C4-1A1D-4DC6-83A8-E416F9E1E7E8Q36635727-68A21C34-E34E-4BEF-93A9-87B5465056D3Q36716030-575AB104-8D2C-4729-9F93-707136ACA5CAQ36716062-BBF6BBD2-C2B8-4C2A-8DAC-01C865AF239FQ36848937-4DF2C287-9912-4CD1-8DBF-01F0369460FFQ36911098-7B3DFBA5-EAAF-4EB6-BF81-E218A3D57770Q36965630-B2E4D650-1B51-4901-B43E-383A737C1307Q37034193-09B33F43-1DAE-4458-B9D6-711683E9A99FQ37086245-41983B3F-CB84-441E-B45E-F69F60137402Q37141727-8D3CD47B-31D6-4FC6-A962-AA5565C085EEQ37190101-2B4828CB-B81B-4B1A-9F64-9E3826040A52Q37359923-792D06DF-A01E-49EE-AB12-4FDE36D5A1F7
P2860
Effect of a sustained reduction in plasma free fatty acid concentration on intramuscular long-chain fatty Acyl-CoAs and insulin action in type 2 diabetic patients.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Effect of a sustained reductio ...... n in type 2 diabetic patients.
@en
Effect of a sustained reductio ...... n in type 2 diabetic patients.
@nl
type
label
Effect of a sustained reductio ...... n in type 2 diabetic patients.
@en
Effect of a sustained reductio ...... n in type 2 diabetic patients.
@nl
prefLabel
Effect of a sustained reductio ...... n in type 2 diabetic patients.
@en
Effect of a sustained reductio ...... n in type 2 diabetic patients.
@nl
P2093
P921
P1433
P1476
Effect of a sustained reductio ...... n in type 2 diabetic patients.
@en
P2093
Anthony Romanelli
Gary W Cline
Lawrence J Mandarino
Mandeep Bajaj
Swangjit Suraamornkul
P304
P356
10.2337/DIABETES.54.11.3148
P407
P577
2005-11-01T00:00:00Z